Compare ASMB & ORN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASMB | ORN |
|---|---|---|
| Founded | 2005 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Military/Government/Technical |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 414.7M | 415.4M |
| IPO Year | 2010 | 2007 |
| Metric | ASMB | ORN |
|---|---|---|
| Price | $26.22 | $13.77 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 4 |
| Target Price | ★ $43.40 | $14.88 |
| AVG Volume (30 Days) | 98.7K | ★ 398.1K |
| Earning Date | 03-19-2026 | 03-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.24 |
| Revenue | $37,191,000.00 | ★ $835,917,000.00 |
| Revenue This Year | $33.33 | $6.66 |
| Revenue Next Year | N/A | $3.73 |
| P/E Ratio | ★ N/A | $58.15 |
| Revenue Growth | ★ 31.30 | 7.02 |
| 52 Week Low | $7.75 | $4.64 |
| 52 Week High | $39.71 | $15.00 |
| Indicator | ASMB | ORN |
|---|---|---|
| Relative Strength Index (RSI) | 43.34 | 64.91 |
| Support Level | $25.47 | $12.24 |
| Resistance Level | $27.50 | $15.00 |
| Average True Range (ATR) | 1.75 | 0.81 |
| MACD | 0.23 | 0.06 |
| Stochastic Oscillator | 35.04 | 64.53 |
Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.
Orion Group Holdings Inc is a specialty construction company serving the infrastructure, industrial, and building sectors, providing services both on and off the water in the continental United States, Alaska, Canada and the Caribbean Basin through its marine segment and its concrete segment. Its marine segment provides construction and dredging services relating to marine transportation facility construction, marine pipeline construction, marine environmental structures, dredging of waterways, channels and ports, environmental dredging, design, and specialty services. Its concrete segment provides turnkey concrete construction services including pour and finish, dirt work, layout, forming, rebar and mesh across the light commercial, structural and other associated business areas.